However, there was no significant heterogeneity in the associations comparing ER+ and ER− (p = 0.11), PR+ and PR− (p = 0.18) or ER+/PR+ and ER−/PR− breast cancer (p = 0.09). This evidence concerns the gene PGR and breast carcinoma.